Internal Medicine, Hematology & Oncology · West Reading, PA
NPI
1538111307
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
3
Medicare group memberships
Hospitals
2
Hospital affiliations
S 6th Avenue & Spruce St, Trhmc Regional Cancer Center N Ground
West Reading, PA, 19611
Phone (610) 374-4404
Groups this clinician bills Medicare through
Medicare paid, 2024
$49K
652 services
Medicare patients, 2024
359
Average age 74
Drug cost, 2024
$3.8M
1,817 prescriptions
Company payments, 2025
$40.52
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Nick C Leasure was code 99214 (office e&m - established), 449 times for 286 patients. In total Nick C Leasure billed 652 services in 13 codes, and Medicare paid $49K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-02-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 449 | 286 | $65.50 | $29K |
| 99215 Office E&M - Established | Facility | 98 | 65 | $99.40 | $9,742 |
| 99205 Office E&M - New | Facility | 42 | 42 | $131.82 | $5,537 |
| 99213 Office E&M - Established | Facility | 20 | 20 | $47.91 | $958 |
| 38222 Other Organ Systems | Facility | 15 | 15 | $56.82 | $852 |
By year: 2022 $49K for 629 services; 2023 $54K for 685 services; 2024 $49K for 652 services.
Medicare prescription drug claims, 2024
In 2024, the drug Nick C Leasure prescribed most often to Medicare patients was Anastrozole, with 856 prescriptions and refills. In total Nick C Leasure wrote 1,817 Medicare prescriptions that cost $3.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 856 | 2,317 | 255 | $24K |
| Letrozole Generic | 219 | 632 | 80 | $6,714 |
| Ibrance Palbociclib | 138 | 138 | 15 | $2.1M |
| Eliquis Apixaban | 58 | 78 | 12 | $43K |
| Prochlorperazine Maleate Generic | 54 | 54 | 32 | $497 |
| Dexamethasone Generic | 42 | 43 | 15 | $361 |
| Verzenio Abemaciclib | 29 | 29 | Under 11 | $422K |
| Xarelto Rivaroxaban | 27 | 53 | Under 11 | $29K |
| Tamoxifen Citrate Generic | 26 | 58 | Under 11 | $540 |
| Gabapentin Generic | 25 | 30 | Under 11 | $247 |
| Ondansetron Odt Ondansetron | 24 | 25 | 20 | $307 |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 20 | 20 | 15 | $238 |
| Ondansetron Hcl Generic | 20 | 20 | 13 | $110 |
| Hydroxyurea Generic | 19 | 57 | Under 11 | $398 |
| Oxycodone Hcl Generic | 18 | 18 | Under 11 | $633 |
Brand drugs: 321 claims; generic drugs: 1,496 claims; opioid claims: 50.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Nick C Leasure $40.52 ($40.52 in general payments such as food, travel and fees) from 2 companies. The largest payer was Incyte Corporation with $28.1.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.